Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 18, 2006

Amgen Breaks Ground on $38M Expansion of Louisville Distribution Center

  • Amgen is enlarging its Louisville, Kentucky, distribution center. The $38 million expansion and improvement project will add 27,000 sq.ft. to the existing building’s infrastructure and provide additional jobs. The expansion is slated for completion in 2007.

    "The expansion of our Louisville Distribution Center will help enable Amgen to meet growing demand for our current marketed products and prepare for new medicines from our pipeline in the years ahead," said Dennis Fenton, Amgen executive vp, operations.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »